Stroke, Vol 14, 876-882, Copyright © 1983 by American Heart Association
S Sadoshima, M Fujishima, J Ogata, S Ibayashi, O Shiokawa and T Omae
The present study was designed to clarify the relationship of cerebral
blood flow (CBF) to blood-brain barrier (BBB) in the ischemic brains with
or without recirculation, which were produced by clipping of both common
carotid arteries in spontaneously hypertensive rats. CBF was measured by
the hydrogen clearance method and BBB function was evaluated by the
permeability of 131I-albumin and Evans blue dye. Cortical CBF was reduced
from 48.8 +/- 9.5 to 4.0 +/- 1.2 ml/100 gm/min during 1 hr ischemia and
further to 2.6 +/- 0.3 ml/100 gm/min during 3 hrs ischemia, while thalamic
CBF was reduced much less from 50.0 +/- 3.6 to 17.9 +/- 6.5 ml/100 gm/min
and to 17.5 +/- 11.0 ml/100 gm/min, respectively. There was no increase in
permeability to protein tracers observed in such 1 hr or 3 hrs ischemic
brain. Both cortical and thalamic CBF were markedly increased 2.5 to 6 fold
of resting values at 5 min after recirculation in the 1 hr ischemic brain.
In the 3 hrs ischemic brain, however, both CBF were only slightly increased
but never restored to the resting level even at 30 min after recirculation.
In such reperfused brains, exudation to Evans blue dye was observed in none
of 16 animals with 1 hr ischemia, but in 18 of 23 with 3 hrs ischemia.
Disruption of BBB was twice more frequent in the cortex (77.8%) than in
either thalamus (33.3%) or hippocampus (33.3%). Permeability index of
131I-albumin (brain albumin/blood albumin) was significantly higher in the
ischemic areas stained with blue dye (2.07 +/- 0.45%) than in non-ischemic
control brain (0.10 +/- 0.01%).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Disruption of blood-brain barrier following bilateral carotid artery occlusion in spontaneously hypertensive rats. A quantitative study
This article has been cited by other articles:
![]() |
T. J. Abbruscato and T. P. Davis Combination of Hypoxia/Aglycemia Compromises In Vitro Blood-Brain Barrier Integrity J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 668 - 675. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1983 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |